Efficacy of combination antihypertensive therapy with low-dose indapamide: Assessment by blood pressure self-monitoring at home

Clinical and Experimental Hypertension

Volumn 27, Issue 4, 2005, Pages 331-341

  Hashimoto, Junichiro ^a,b   Hirayama, Hiroaki ^a   Hanasawa, Tomohiro ^a   Watabe, Daisuke ^a   Asayama, Kei ^a   Metoki, Hirohito ^a   Kikuya, Masahiro ^a   Ohkubo, Takayoshi ^a,b   Totsune, Kazuhito ^a,b   Imai, Yutaka ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Chronopharmacology; Combination therapy; Home blood pressure; Indapamide; Self monitoring

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; INDAPAMIDE; LISINOPRIL; LOSARTAN; NIFEDIPINE; NISOLDIPINE; PERINDOPRIL; QUINAPRIL; UNCLASSIFIED DRUG; VALNIDIPINE; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; HUMAN; HYPERTENSION; MONOTHERAPY; PULSE PRESSURE; SELF MONITORING; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 21044438880     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200057421     Document Type: Conference Paper

References (29)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289:2560-2572.
2. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
3. 2+ entry into vascular smooth muscle cells. Nephron 1997; 76:460-465.
4. Hall WD, Weber MA, Ferdinand K, Flamenbaum W, Marbury T, Jain AK, Weilder D, Weiss R, Herron J, Codispoti J, Stokes A, McNally C. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension. J Hum Hypertens 1994; 8:571-575.
5. Weiss R, Toth P, Miller EE, Zellner SR, Shook M, Codispoti J, Stokes A, McNally C. Clinical efficacy and safety of lower-dose indapamide therapy in the treatment of patients with mild to moderate hypertension. Am J Ther 1994; 1:58-64.
6. Myers M, Asmar R, Leenen F, Safar M. Fixed low-dose combination therapy in hypertension. A dose response study of perindopril and indapamide. J Hypertens 2000; 18:317-325.
7. Pickering TG, for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995; 9:1-11.
8. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
9. Stergiou GS, Efstathiou SP, Skeva II, Baibas NM, Kalkana CB, Mountokalakis TD. Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. J Hum Hypertens 2002; 16:729-735.
10. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, Chonan K, Kikuya M, Satoh H, Hisamichi S, Nagai K. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19:179-185.
11. Vaur L, Dubroca I, Dutrey-Dupagne C, Genes N, Chatellier G, Bouvier-d'Yvoire M, Elkik F, Menard J. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit 1998; 3:107-114.
12. Menard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens 1994; 12(suppl 8):S21-S25.
13. Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Chatellier G, Elkik F, Menard J. Assessment of drug efficacy using home self-blood pressure measurement: the SMART study. J Hum Hypertens 1996; 10:341-347.
14. Hashimoto J, Chonan K, Aoki Y, Ugajin T, Yamaguchi J, Nishimura T, Kikuya M, Michimata M, Matsubara M, Araki T, Hozawa A, Ohkubo T, Imai Y. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertens 2003; 21:805-811.
15. Mengden T, Battig B, Vetter W. Self-measurement of blood pressure improves the accuracy and the number of subjects in clinical trials. J Hypertens 1991; 9(suppl 6):S336-S337.
16. Waeber B, Brunner HR. Rational for the use of very-low-dose combinations as first-line treatment of hypertension. J Hypertens 2001; 19(suppl 4):S3-S8.
17. Krekels MM, Gaillard CA, Viergever PP, Van Es PN, Lavrijssen AT, De Leeuw PW. Natriuretic effect of nitrendipine is preceded by transient systemic and renal hemodynamic effects. Cardiovasc Drugs Ther 1997; 11:33-38.
18. Stergiou GS, Malakos JS, Achimastos AD, Mountokalakis TD. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring. J Cardiovasc Pharmacol 1997; 29:412-416.
19. Asmar R, Lacourciere Y. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. J Hypertens 2000; 18:1683-1690.
20. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30:1410-1415.
21. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home. Arch Intern Med 2000; 160:3301-3306.
22. Cushman WC, Materson BJ, Williams DW, Reda DJ. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Hypertension 2001; 38:953-957.
23. Mallion J-M, Asmar R, Boutelant S, Guez D. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies. J Cardiovasc Pharmacol 1998; 32:673-678.
24. Fenichel RR, Lipicki RJ. On the trough:peak ratio of drug effect in antihypertensive trials. Am J Hypertens 1996; 9:105S-107S.
25. Palatini P. Importance of various methods of blood pressure measurement in clinical trials. Curr Hypertens Rep 2000; 2:362-369.
26. Meredith PA. Trough:peak ratio and smoothness index for antihypertensive agents. Blood Press Monit 1999; 4:257-262.
27. Julius S, Kjeldsen S, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchel L, Plat F, Schork A, Smith B, Zanchetti A, for the VALUE Trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on varsartan or amlodioine: the VALUE randomized trial. Lancet 2004; 363:2022-2031.
28. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of Hypertension Optimal Treatment (HOT) Randomised Trial. HOT Study Group. Lancet 1998; 351:1755-1762.
29. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358:1033-1041.